{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:54:14Z","timestamp":1771268054639,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T00:00:00Z","timestamp":1453248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"publisher","award":["9\/9\/2013"],"award-info":[{"award-number":["9\/9\/2013"]}],"id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40291-015-0184-x","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T14:36:55Z","timestamp":1453300615000},"page":"135-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study"],"prefix":"10.1007","volume":"20","author":[{"given":"Radwa Marawan","family":"AbdelHalim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia Ibrahim","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham","family":"Zeyada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Soliman","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman Atef","family":"Mandour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,20]]},"reference":[{"key":"184_CR1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","volume":"36","author":"L Ghulmiyyah","year":"2012","unstructured":"Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia\/eclampsia. Semin Perinatol. 2012;36:56\u20139.","journal-title":"Semin Perinatol"},{"key":"184_CR2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.devcel.2009.07.011","volume":"17","author":"JC Chappell","year":"2008","unstructured":"Chappell JC, Taylor SM, Ferrara N, Bautch VL. Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev Cell. 2008;17:377\u201386.","journal-title":"Dev Cell"},{"key":"184_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10641950902968635","volume":"29","author":"DO Anumba","year":"2010","unstructured":"Anumba DO, Lincoln K, Robson SC. Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension. Hypertens Pregnancy. 2010;29:163\u201379.","journal-title":"Hypertens Pregnancy."},{"key":"184_CR4","doi-asserted-by":"crossref","unstructured":"Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol. 2009;200:98.e1\u20136.","DOI":"10.1016\/j.ajog.2008.07.063"},{"key":"184_CR5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ajh\/hpt187","volume":"26","author":"ML Miranda","year":"2013","unstructured":"Miranda ML, Macher HC, Mu\u00f1oz-Hern\u00e1ndez R, Vallejo-Vaz A, Moreno-Luna R, Villar J, et al. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome. Am J Hypertens. 2013;26:1377\u201380.","journal-title":"Am J Hypertens"},{"key":"184_CR6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/pd.4416","volume":"34","author":"A Martin","year":"2014","unstructured":"Martin A, Krishna I, Martina B, Samuel A. Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review. Prenat Diagn. 2014;34:685\u201391.","journal-title":"Prenat Diagn"},{"key":"184_CR7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/pd.3995","volume":"32","author":"I Kaufmann","year":"2012","unstructured":"Kaufmann I, Rusterholz C, H\u00f6sli I, Hahn S, Lapaire O. Can detection of late-onset PE at triage by sflt-1 or PlGF be improved by the use of additional biomarkers? Prenat Diagn. 2012;32:1288\u201394.","journal-title":"Prenat Diagn"},{"key":"184_CR8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2004.12.023","volume":"193","author":"A Farina","year":"2005","unstructured":"Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2005;193:421\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"184_CR9","doi-asserted-by":"crossref","unstructured":"Al Nakib M, Desbriere R, Bonello N, Bretelle F, Boubli L, Gabert J, et al. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther. 2009;26:24\u20138.","DOI":"10.1159\/000236355"},{"key":"184_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000346806","volume":"33","author":"LC Poon","year":"2013","unstructured":"Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH. Maternal plasma cell-free fetal and maternal DNA at 11\u201313\u00a0weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther. 2013;33:215\u201323.","journal-title":"Fetal Diagn Ther"},{"key":"184_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2012.09.006","volume":"166","author":"W Stein","year":"2013","unstructured":"Stein W, M\u00fcller S, Gutensohn K, Emons G, Legler T. Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol. 2013;166:10\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"184_CR12","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.3390\/ijms14047571","volume":"14","author":"H Yu","year":"2013","unstructured":"Yu H, Shen Y, Ge Q, He Y, Qiao D, Ren M, et al. Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia. Int J Mol Sci. 2013;14:7571\u201382.","journal-title":"Int J Mol Sci"},{"key":"184_CR13","first-page":"274","volume":"34","author":"MS Quezada","year":"2014","unstructured":"Quezada MS, Francisco C, Dumitrascu-Biris K, Nicolaides KH, Poon LC. Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2014;34:274\u201382.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"184_CR14","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1373\/clinchem.2005.051235","volume":"51","author":"B Zimmermann","year":"2005","unstructured":"Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem. 2005;51:1598\u2013604.","journal-title":"Clin Chem"},{"key":"184_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1196\/annals.1368.047","volume":"1075","author":"G Zimmermann","year":"2006","unstructured":"Zimmermann G, Holzgreve W, Avent N, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Ann N Y Acad Sci. 2006;1075:347\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"184_CR16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642\u20139.","journal-title":"Nat Med"},{"key":"184_CR17","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/ndt\/gfl439","volume":"21","author":"FC Luft","year":"2006","unstructured":"Luft FC. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFLT) receptor as a preeclampsia molecule. Nephrol Dial Transplant. 2006;21:3052\u20134.","journal-title":"Nephrol Dial Transplant"},{"key":"184_CR18","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1210\/jc.2006-2774","volume":"92","author":"H Stepan","year":"2007","unstructured":"Stepan H, Kramer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 2007;92:2831\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"184_CR19","doi-asserted-by":"crossref","first-page":"e4453","DOI":"10.1371\/journal.pone.0004453","volume":"4","author":"A Reddy","year":"2009","unstructured":"Reddy A, Suri S, Sargent IL, Redman CW, Muttukrishna S. Maternal circulating levels of activin A, inhibin A, sflt-1 and endoglin at parturition in normal pregnancy and pre eclampsia. PLoS One. 2009;4:e4453.","journal-title":"PLoS One"},{"key":"184_CR20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.placenta.2008.03.006","volume":"29","author":"A Jeyabalan","year":"2008","unstructured":"Jeyabalan A, McGonigal S, Gilmour C, Hubel CA, Rajakumar A. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta. 2008;29:555\u201363.","journal-title":"Placenta"},{"key":"184_CR21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"The American College of Obstetricians and Gynecologists","year":"2013","unstructured":"The American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122\u201331.","journal-title":"Obstet Gynecol"},{"key":"184_CR22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.MJX.0000429694.24609.5c","volume":"12","author":"W El-Garf","year":"2013","unstructured":"El-Garf W, Salem M, Osman O, El Sirgany S, Bibers M, Salama SH, et al. Plasma circulating cell-free DNA and uteroplacental blood flow in preeclamptic patients. Med Res J. 2013;12:6\u201311.","journal-title":"Med Res J."},{"key":"184_CR23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","volume":"62","author":"YMD Lo","year":"1998","unstructured":"Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768\u201375.","journal-title":"Am J Hum Genet"},{"key":"184_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/clinchem\/45.2.184","volume":"45","author":"YM Lo","year":"1999","unstructured":"Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45:184\u20138.","journal-title":"Clin Chem"},{"key":"184_CR25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mob.2001.109594","volume":"184","author":"XY Zhong","year":"2001","unstructured":"Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184:414\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"184_CR26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pd.965","volume":"24","author":"A Sekizawa","year":"2004","unstructured":"Sekizawa A, Farina A, Koide K, Iwasaki M, Honma S, Ichizuka K, et al. Beta-globin DNA in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn. 2004;24:697\u2013700.","journal-title":"Prenat Diagn"},{"key":"184_CR27","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pd.973","volume":"24","author":"A Farina","year":"2004","unstructured":"Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cell-free DNA (b-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn. 2004;24:722\u20136.","journal-title":"Prenat Diagn"},{"key":"184_CR28","doi-asserted-by":"crossref","unstructured":"Sifakis S, Zaravinos A,\u00a0Maiz N, Spandidos DA, Nicolaides KH. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol. 2009;201:472.e1\u20137.","DOI":"10.1016\/j.ajog.2009.05.025"},{"key":"184_CR29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1447-0756.2012.02011.x","volume":"39","author":"YG Zeybek","year":"2013","unstructured":"Zeybek YG, G\u00fcnel T, Benian A, Ayd\u0131nl K, Kaleli S. Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies. J Obstet Gynaecol Res. 2013;39:632\u201340.","journal-title":"J Obstet Gynaecol Res."},{"key":"184_CR30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1196\/annals.1368.015","volume":"1075","author":"A Gupta","year":"2006","unstructured":"Gupta A, Hasler P, Gebhardt S, Holzgreve W, Hahn S. Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA? Ann N Y Acad Sci. 2006;1075:118\u201322.","journal-title":"Ann N Y Acad Sci"},{"key":"184_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.placenta.2004.01.005","volume":"18","author":"DW Bianchi","year":"2004","unstructured":"Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential: a review. Placenta. 2004;18:93\u2013101.","journal-title":"Placenta"},{"key":"184_CR32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.placenta.2004.10.017","volume":"26","author":"S Hahn","year":"2005","unstructured":"Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta. 2005;26:515\u201326.","journal-title":"Placenta"},{"key":"184_CR33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2353\/ajpath.2006.060161","volume":"169","author":"ML Tjoa","year":"2006","unstructured":"Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol. 2006;169:400\u20134.","journal-title":"Am J Pathol"},{"key":"184_CR34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2008.055236","volume":"61","author":"DJ Roberts","year":"2008","unstructured":"Roberts DJ, Post MD. The placenta in preeclampsia and intrauterine growth restriction. J Clin Pathol. 2008;61:1254\u201360.","journal-title":"J Clin Pathol"},{"key":"184_CR35","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/trf.12073","volume":"53","author":"TR Jakobsen","year":"2013","unstructured":"Jakobsen TR, Clausen FB, Rode L, Dziegiel MH, Tabor A. Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA. Transfusion. 2013;53:1956\u201364.","journal-title":"Transfusion."},{"key":"184_CR36","doi-asserted-by":"crossref","first-page":"e48259","DOI":"10.1371\/journal.pone.0048259","volume":"10","author":"S Rana","year":"2012","unstructured":"Rana S, Cerdeira AS, Wenger J, Salahuddin S, Lim K, Ralston SJ, et al. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One. 2012;10:e48259.","journal-title":"PLoS One"},{"key":"184_CR37","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1291\/hypres.31.1541","volume":"31","author":"C Hirashima","year":"2008","unstructured":"Hirashima C, Ohkuchi A, Matsubara S, Suzuki H, Takahashi K, Usui R, et al. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res. 2008;31:1541\u20138.","journal-title":"Hypertens Res"},{"key":"184_CR38","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.4049\/jimmunol.1103454","volume":"188","author":"A Scharfe-Nugent","year":"2012","unstructured":"Scharfe-Nugent A, Corr SC, Carpenter SB, Keogh L, Doyle B, Martin C, et al. TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J Immunol. 2012;188:5706\u201312.","journal-title":"J Immunol."},{"key":"184_CR39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3109\/14767050902994838","volume":"22","author":"T Chaiworapongsa","year":"2009","unstructured":"Chaiworapongsa T, Romero R, Tarca A, Kusanovic JP, Mittal P, Kim SK, et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic\/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogenity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med. 2009;22:1122\u201339.","journal-title":"J Matern Fetal Neonatal Med."},{"key":"184_CR40","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1210\/endo.138.11.5475","volume":"138","author":"I Caniggia","year":"1997","unstructured":"Caniggia I, Taylor CV, Ritchie JW, Lye SJ, Letarte M. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology. 1997;138:4977\u201388.","journal-title":"Endocrinology"},{"key":"184_CR41","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI6380","volume":"103","author":"I Caniggia","year":"1999","unstructured":"Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest. 1999;103:1641\u201350.","journal-title":"J Clin Invest."},{"key":"184_CR42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1067\/mob.2003.27","volume":"188","author":"A Sekizawa","year":"2003","unstructured":"Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol. 2003;188:480\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"184_CR43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pd.965","volume":"24","author":"A Sekizawa","year":"2004","unstructured":"Sekizawa A, Farina A, Koide K, Iwasaki M, Honma S, Ichizuka K, et al. Beta-globin DNA in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn. 2004;24:697\u2013700.","journal-title":"Prenat Diagn"},{"key":"184_CR44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/pd.1504","volume":"26","author":"M Smid","year":"2006","unstructured":"Smid M, Galbiati S, Lojacono A, Valsecchi L, Platto C, Cavoretto P, et al. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn. 2006;26:785\u201390.","journal-title":"Prenat Diagn"},{"key":"184_CR45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","volume":"21","author":"O Erez","year":"2008","unstructured":"Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21:279\u201387.","journal-title":"J Matern Fetal Neonatal Med."},{"key":"184_CR46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpm-2013-0082","volume":"41","author":"T Chaiworapongsa","year":"2013","unstructured":"Chaiworapongsa T, Romero R, Whitten A, Tarca AL, Bhatti G, Draghici S, et al. Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsia. J Perinat Med. 2013;41:485\u2013504.","journal-title":"J Perinat Med"},{"key":"184_CR47","first-page":"1","volume":"57","author":"MF MacDorman","year":"2009","unstructured":"MacDorman MF, Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep. 2009;57:1\u201319.","journal-title":"Natl Vital Stat Rep."},{"key":"184_CR48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785\u201399.","journal-title":"Lancet."},{"key":"184_CR49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","volume":"22","author":"JP Kusanovic","year":"2009","unstructured":"Kusanovic JP, Romero R, Chaiworapongsa Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009;22:1021\u201338.","journal-title":"J Matern Fetal Neonatal Med."},{"key":"184_CR50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402\u201314.","journal-title":"Obstet Gynecol"},{"key":"184_CR51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","volume":"31","author":"S Roberge","year":"2012","unstructured":"Roberge S, Villa P, Nicolaides K, Gigu\u00e8re Y, Vainio M, Bakthi A, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31:141\u20136.","journal-title":"Fetal Diagn Ther"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-015-0184-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0184-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:00:28Z","timestamp":1718316028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-015-0184-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,20]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1007\/s40291-015-0184-x","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,20]]}}}